SEC reporting owner
| Reporting owner CIK | 0001443340 |
|---|---|
| Issuers | 5 |
| Qualifying disclosures | 1,322 |
| Public purchases | 9 |
| Recent-window purchases | 2 |
| Recent-window sales | 4 |
| Last public filing | 2026-08-08 |
| Coverage | verified |
| Directory rank | 100 |
| Publicly available | Trade date | Ticker | Code | Shares | Reported value |
|---|---|---|---|---|---|
| 2026-08-07 | 2026-08-05 | MRNA | S | 187,044 | Not reported |
| 2026-08-07 | 2026-08-05 | MRNA | S | 39,891 | Not reported |
| 2026-08-07 | 2026-08-05 | MRNA | S | 124,838 | Not reported |
| 2026-08-07 | 2026-08-05 | MRNA | S | 147,473 | Not reported |
| 2026-03-03 | 2026-03-01 | MRNA | A | 250,932 | Not reported |
| 2026-03-02 | 2026-02-26 | GENB | A | 29,561 | Not reported |
| 2026-02-13 | 2026-02-11 | MRNA | A | 11,271 | Not reported |
| 2025-03-04 | 2025-03-03 | MRNA | P | 57,493 | Not reported |
| 2025-03-04 | 2025-03-03 | MRNA | P | 102,821 | Not reported |
| 2025-03-03 | 2025-03-01 | MRNA | A | 357,065 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.